TELA Bio Long-Term Debt 2011-2026 | TELA

Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.

Main characteristics:

Term exceeds 12 months
Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
Repaid through regular payments (interest and/or principal) over several years

Why long-term debt is needed:

Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital.
Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks.
Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.

A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.

If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.

It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.

Examples of long-term debt:

Mortgage loans for property purchases
Corporate bonds issued by a company to raise capital
Project financing — long-term loans for building or expanding production facilities
Leasing obligations for equipment or transport

Annual Long-Term Debt TELA Bio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
55.7 M	41.1 M	40.5 M	39.9 M	31.5 M	30.8 M	30.2 M	29.7 M	3.61 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
55.7 M	3.61 M	33.7 M

Quarterly Long-Term Debt TELA Bio

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
41.5 M	38.1 M	41.3 M	41.1 M	41 M	40.8 M	-	40.5 M	40.4 M	40.2 M	40.1 M	39.9 M	39.8 M	39.6 M	31.7 M	31.5 M	31.3 M	31.1 M	31 M	30.8 M	30.8 M	30.8 M	30.8 M	30.2 M	30.2 M	30.2 M	30.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
41.5 M	30.2 M	35.6 M

Long-Term Debt of other stocks in the Medical devices industry

Issuer	Long-Term Debt	Price	% 24h	Market Cap	Country
GenMark Diagnostics, Inc. GNMK	71.3 M	-	-	$ 1.77 B	USA
Acutus Medical AFIB	32.7 M	-	-26.83 %	$ 2.62 M	USA
AdaptHealth Corp. AHCO	1.72 B	$ 12.07	0.33 %	$ 1.63 B	USA
Allied Healthcare Products AHPI	2.93 K	-	3.58 %	$ 2.21 M	USA
EDAP TMS S.A. EDAP	2 M	$ 3.45	1.77 %	$ 129 M	France
Obalon Therapeutics, Inc. OBLN	430 K	-	-5.86 %	$ 30.6 M	USA
Apollo Endosurgery APEN	34 M	-	-	$ 475 M	USA
CryoLife, Inc. CRY	290 M	-	-4.14 %	$ 702 M	USA
Avinger AVGR	1.1 M	-	-20.74 %	$ 369 K	USA
Align Technology ALGN	88.2 M	$ 171.87	0.74 %	$ 12.9 B	USA
AxoGen AXGN	48.4 M	$ 32.64	-5.23 %	$ 1.5 B	USA
Axonics Modulation Technologies AXNX	7.56 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	3.59 M	-	1.37 %	$ 20.5 M	USA
Itamar Medical Ltd. ITMR	154 K	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	38.6 M	-	-	$ 462 M	USA
Neovasc NVCN	7.64 M	-	-	$ 111 M	Canada
Butterfly Network BFLY	20.4 M	$ 4.13	0.49 %	$ 874 M	USA
Intersect ENT, Inc. XENT	63.6 M	-	-	$ 955 M	USA
BIOLASE BIOL	11.8 M	-	-13.19 %	$ 166 K	USA
Bruker Corporation BRKR	2.06 B	$ 36.74	-0.05 %	$ 5.47 K	USA
BioSig Technologies BSGM	103 K	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	11.1 B	$ 62.59	-0.37 %	$ 92.7 B	USA
Alphatec Holdings ATEC	501 M	$ 10.97	1.29 %	$ 1.65 B	USA
CONMED Corporation CNMD	834 M	-	-	$ 1.06 B	USA
Conformis CFMS	20.6 M	-	-	$ 16.4 M	USA
ClearPoint Neuro CLPT	49.1 M	$ 9.38	0.11 %	$ 266 M	USA
Cardiovascular Systems CSII	1.33 M	-	0.15 %	$ 844 M	USA
Cytosorbents Corporation CTSO	16.7 M	$ 0.59	1.2 %	$ 36.7 M	USA
Cutera CUTR	1.06 M	-	-10.19 %	$ 1.99 M	USA
Delcath Systems DCTH	835 K	$ 9.7	0.73 %	$ 347 M	USA
Dynatronics Corporation DYNT	1.11 M	-	14.99 %	$ 929 K	USA
Eargo EAR	11.9 M	-	-	$ 10.2 M	USA
Edwards Lifesciences Corporation EW	598 M	$ 81.19	0.17 %	$ 47.5 B	USA
Second Sight Medical Products EYES	17.1 M	-	-0.97 %	$ 54.4 M	USA
Electromed ELMD	1.1 M	$ 23.61	1.37 %	$ 200 M	USA
FONAR Corporation FONR	155 K	$ 18.6	0.05 %	$ 122 M	USA
Globus Medical GMED	436 K	$ 88.6	0.77 %	$ 12 B	USA
Helius Medical Technologies HSDT	12 K	$ 1.9	2.15 %	$ 1.15 M	USA
Integra LifeSciences Holdings Corporation IART	760 M	$ 9.31	-2.31 %	$ 717 M	USA
Inogen INGN	14.3 M	$ 6.36	2.42 %	$ 169 M	USA
Inspire Medical Systems INSP	30 M	$ 54.14	-1.55 %	$ 1.59 B	USA
IRIDEX Corporation IRIX	98 K	$ 1.0	1.66 %	$ 16.9 M	USA
IRadimed Corporation IRMD	2 K	$ 95.66	-0.59 %	$ 1.22 B	USA
Integer Holdings Corporation ITGR	1.19 B	$ 85.63	-1.4 %	$ 2.97 B	USA
Invacare Corporation IVC	354 M	-	-	$ 24.7 M	USA
GBS GBS	1.65 M	-	-0.57 %	$ 7.12 M	USA